4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-035619
Options or other derivatives
- Chief Commercial Officer acquired 6,219,696 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Piccina Cintia Chief Commercial Officer | 2024-03-18 | Grant or award · Option to purchase Ordinary Shares | +5,088,864 | 5,088,864 | D | ||
| Piccina Cintia Chief Commercial Officer | 2024-03-18 | Grant or award · Option to purchase Ordinary Shares | +1,130,832 | 1,130,832 | D | ||
Loading xslF345X05/tm249079d1_4seq1.xml…